3.585
Schlusskurs vom Vortag:
$3.55
Offen:
$3.61
24-Stunden-Volumen:
640.56K
Relative Volume:
0.12
Marktkapitalisierung:
$894.81M
Einnahmen:
$251.85M
Nettoeinkommen (Verlust:
$-72.58M
KGV:
-11.44
EPS:
-0.3134
Netto-Cashflow:
$-63.80M
1W Leistung:
-3.38%
1M Leistung:
-7.86%
6M Leistung:
-22.45%
1J Leistung:
-39.92%
Ardelyx Inc Stock (ARDX) Company Profile
Firmenname
Ardelyx Inc
Sektor
Branche
Telefon
510-745-7047
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Vergleichen Sie ARDX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ARDX
Ardelyx Inc
|
3.585 | 894.81M | 251.85M | -72.58M | -63.80M | -0.3134 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
447.75 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
513.82 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
315.17 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
543.10 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
256.14 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-02 | Herabstufung | Raymond James | Strong Buy → Outperform |
2025-03-07 | Fortgesetzt | Ladenburg Thalmann | Buy |
2025-03-04 | Eingeleitet | BTIG Research | Buy |
2024-11-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2024-07-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
2024-04-05 | Eingeleitet | Leerink Partners | Outperform |
2023-12-18 | Eingeleitet | Raymond James | Strong Buy |
2023-09-07 | Eingeleitet | H.C. Wainwright | Buy |
2023-08-25 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2023-03-03 | Hochstufung | Wedbush | Neutral → Outperform |
2022-11-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
2022-05-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2021-12-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
2021-10-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2021-07-21 | Herabstufung | Jefferies | Buy → Hold |
2021-07-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-07-20 | Herabstufung | Wedbush | Outperform → Neutral |
2021-03-23 | Eingeleitet | Wedbush | Outperform |
2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-10-20 | Fortgesetzt | Citigroup | Buy |
2020-02-18 | Fortgesetzt | Jefferies | Buy |
2020-02-12 | Eingeleitet | Citigroup | Buy |
2020-02-10 | Eingeleitet | Cowen | Outperform |
2019-04-08 | Eingeleitet | Piper Jaffray | Overweight |
2018-08-24 | Eingeleitet | Jefferies | Buy |
2018-03-19 | Fortgesetzt | Leerink Partners | Outperform |
2017-11-29 | Bestätigt | Citigroup | Buy |
2017-11-22 | Bestätigt | Ladenburg Thalmann | Buy |
2017-10-17 | Fortgesetzt | Leerink Partners | Outperform |
2016-03-31 | Eingeleitet | Ladenburg Thalmann | Buy |
2016-03-09 | Eingeleitet | Cantor Fitzgerald | Buy |
2016-03-03 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
ARDX Gains Attention with HC Wainwright & Co. Buy Rating | ARDX Stock News - GuruFocus
H.C. Wainwright assumes coverage on Ardelyx stock with buy rating By Investing.com - Investing.com India
Ardelyx (ARDX) Receives Positive Coverage with Buy Rating and $10 Target | ARDX Stock News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc.ARDX - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. ... - Bluefield Daily Telegraph
Hedge Fund and Insider Trading News: Paul Tudor Jones, Divya Nettimi, Scott Bessent, Marshall Wace, Warren Buffett, Rokos Capital Management, Ardelyx Inc (ARDX), Ralph Lauren Corp (RL), and More - Insider Monkey
Director David Mott Acquires 200,000 Shares of Ardelyx Inc (ARDX) - GuruFocus
Ardelyx director David Mott acquires $737,260 in stock By Investing.com - Investing.com South Africa
Ardelyx director David Mott acquires $737,260 in stock - Investing.com
ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com
Ardelyx is hiring: Director, Marketing in New York at Ardelyx Job - Mediabistro
Transcript : Ardelyx, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08 - marketscreener.com
Ardelyx at Jefferies Conference: Strategic Growth and Market Challenges By Investing.com - Investing.com India
Ardelyx at Jefferies Conference: Strategic Growth and Market Challenges - Investing.com
Ardelyx is hiring: Director, Marketing in Waltham at Ardelyx Job - Mediabistro
Ardelyx reshuffles leadership, adds new HR chief By Investing.com - Investing.com South Africa
Ardelyx appoints Mike Kelliher Chief Business Officer - TipRanks
Ardelyx Promotes Mike Kelliher to Chief Business Officer - marketscreener.com
Ardelyx reshuffles leadership, adds new HR chief - Investing.com Australia
Ardelyx (ARDX) Appoints New Leadership in Strategic Roles | ARDX Stock News - GuruFocus
Ardelyx Appoints Mike Kelliher Chief Business Officer - marketscreener.com
Ardelyx Appoints Mike Kelliher Chief Business Officer and James - GuruFocus
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer - The Manila Times
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer | ARDX Stock News - GuruFocus
Ardelyx Expands Leadership: Strategic Promotion and Key Executive Hire Signal Growth Push - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.
Ardelyx, Inc. (ARDX) Stock Analysis: Investors Eye a Promising 167.99% Upside Potential - DirectorsTalk Interviews
Learn to Evaluate (ARDX) using the Charts - news.stocktradersdaily.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
2 ‘Strong Buy’ Small-Cap Stocks With Blockbuster Potential - The Globe and Mail
Deutsche Bank AG Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Ardelyx chief medical officer sells shares worth $26,206 By Investing.com - Investing.com South Africa
Ardelyx CFO sells $29,459 in stock By Investing.com - Investing.com South Africa
Ardelyx chief medical officer sells shares worth $26,206 - Investing.com Australia
Ardelyx officer Mike Kelliher sells $59,270 in stock By Investing.com - Investing.com South Africa
Ardelyx CFO sells $29,459 in stock - Investing.com Australia
Ardelyx officer Mike Kelliher sells $59,270 in stock - Investing.com Australia
Ardelyx Executives Sell Shares to Cover Taxes - TradingView
Upper Peninsula ABC 10News, Sports, Weather and More from Michigan's Upper Peninsula - FinancialContent
Finanzdaten der Ardelyx Inc-Aktie (ARDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ardelyx Inc-Aktie (ARDX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Williams Laura A | Chief Medical Officer |
May 20 '25 |
Sale |
4.08 |
6,421 |
26,207 |
402,583 |
Renz Justin A | Chief Financial Officer |
May 20 '25 |
Sale |
4.08 |
7,218 |
29,460 |
416,089 |
RAAB MICHAEL | President & CEO |
May 20 '25 |
Sale |
4.08 |
46,817 |
191,079 |
1,547,937 |
Kelliher Mike | See Remarks |
May 20 '25 |
Sale |
4.08 |
14,522 |
59,270 |
282,158 |
GRAMMER ELIZABETH A | See Remarks |
May 20 '25 |
Sale |
4.08 |
5,992 |
24,456 |
311,731 |
Foster Eric Duane | Chief Commercial Officer |
May 20 '25 |
Sale |
4.08 |
2,507 |
10,232 |
316,806 |
MOTT DAVID M | Director |
May 15 '25 |
Buy |
3.29 |
100,000 |
329,120 |
2,496,871 |
MOTT DAVID M | Director |
May 02 '25 |
Buy |
4.22 |
381,377 |
1,610,936 |
2,396,871 |
RAAB MICHAEL | President & CEO |
May 02 '25 |
Option Exercise |
0.99 |
20,833 |
20,625 |
1,636,420 |
RAAB MICHAEL | President & CEO |
May 02 '25 |
Sale |
4.25 |
41,666 |
177,168 |
1,594,754 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):